I

Icecure Medical Ltd
TASE:ICCM

Watchlist Manager
Icecure Medical Ltd
TASE:ICCM
Watchlist
Price: 425.9 ILS 0.12% Market Closed
Market Cap: 193.3m ILS

Icecure Medical Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Icecure Medical Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
I
Icecure Medical Ltd
TASE:ICCM
Net Income (Common)
-$17m
CAGR 3-Years
-52%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Net Income (Common)
$6.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Net Income (Common)
$149.8m
CAGR 3-Years
-5%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Net Income (Common)
$20.6m
CAGR 3-Years
-17%
CAGR 5-Years
10%
CAGR 10-Years
N/A
A
Alpha Tau Medical Ltd
NASDAQ:DRTS
Net Income (Common)
-$31.8m
CAGR 3-Years
-5%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Net Income (Common)
-$4.5m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Icecure Medical Ltd
Glance View

Market Cap
193.3m ILS
Industry
Health Care

IceCure Medical Ltd. is a commercial stage medical device company, which engages in the research and development, design, manufacture, and marketing of cryoablation systems and technologies based on liquid nitrogen for the treatment of tumors. The firm develops and markets minimally invasive cryoablation therapies for women’s health and general oncology market. Icecure Medical Ltd’s proprietary IceSense3 and ProSense systems provide minimally invasive, in-office definitive treatment for symptomatic tumors in various organs. The procedure is done under ultrasound or Computed Tomography (CT) imaging to guide a small probe (thin hollow needle) into the tumor. The system then uses extremely cold temperatures to destroy (ablate) the targeted tumor in situ. Icecure Medical Ltd supports investigator-initiated studies at various academic institutions around the globe, including Kameda and Saint Johns.

ICCM Intrinsic Value
Not Available
I

See Also

What is Icecure Medical Ltd's Net Income (Common)?
Net Income (Common)
-17m USD

Based on the financial report for Dec 31, 2022, Icecure Medical Ltd's Net Income (Common) amounts to -17m USD.

What is Icecure Medical Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-42%

Over the last year, the Net Income (Common) growth was -72%. The average annual Net Income (Common) growth rates for Icecure Medical Ltd have been -52% over the past three years , -42% over the past five years .

Back to Top